These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6785360)

  • 1. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK; Sen DK
    J Indian Med Assoc; 1980 Nov; 75(9):173-4. PubMed ID: 6785360
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Adjuvant intravesical thiotepa and bladder tumour recurrence.
    Boyd PJ; Burnand KG
    Br J Surg; 1975 Feb; 62(2):162. PubMed ID: 803851
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
    Toulouse J; Bouffier B; Etievent JP; Bittard M
    J Urol (Paris); 1983; 89(2):85-9. PubMed ID: 6408192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The recurrence after conservative therapy of bladder cancer. II: The intravesical instillation of anti-cancer drug for preventing recurrence (author's transl)].
    Saito K; Fukushima S; Takahashi Y; Takai S
    Nihon Hinyokika Gakkai Zasshi; 1980 May; 71(5):449-57. PubMed ID: 6774151
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thio-tepa in the prevention of recurrences of papillary bladder tumors].
    Kierfeld G; Mellin P
    Z Urol Nephrol; 1973 Aug; 66(8):569-72. PubMed ID: 4204011
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical treatment with thiotepa: an update review.
    Fosså SD
    Prog Clin Biol Res; 1984; 162B():163-8. PubMed ID: 6438640
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytostatic prophylactic treatment of superficial bladder tumours].
    Lunglmayr G
    Urologe A; 1972 Mar; 11(2):94-7. PubMed ID: 4623214
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study.
    Fosså SD; Miller A; Stenwig AE
    Eur Urol; 1983; 9(4):207-10. PubMed ID: 6409615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B; Gallego J; Boronat F; Moreno B; Mompó JA; Jiménez JF
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemoprophylaxis with intravesical thiotepa in non-infiltrating bladder tumors].
    Lancina Martín J; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1986 Sep; 39(7):479-83. PubMed ID: 3099658
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
    Zhang SX; Deng XZ; Tang XD
    Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of intravesical thiotepa in superficial bladder tumours.
    Kulkarni JN; Kamat MR; Juvekar RL
    Indian J Cancer; 1981 Sep; 18(3):222-4. PubMed ID: 6796504
    [No Abstract]   [Full Text] [Related]  

  • 15. Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors.
    Llopis B; Gallego J; Mompó JA; Boronat F; Jiménez JF
    Eur Urol; 1985; 11(2):73-8. PubMed ID: 3924624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder.
    Pan JS; Slocum HK; Rustum YM; Greco WR; Gaeta JF; Huben RP
    J Urol; 1989 Dec; 142(6):1589-93. PubMed ID: 2511340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour.
    Masters JR; McDermott BJ; Harland S; Bibby MC; Loadman PM
    Cancer Chemother Pharmacol; 1996; 38(1):59-64. PubMed ID: 8603453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early multiple-dose adjuvant thiotepa in the control of multiple and rapid T1 tumour neogenesis.
    England HR; Flynn JT; Paris AM; Blandy JP
    Br J Urol; 1981 Dec; 53(6):588-92. PubMed ID: 6797501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers.
    Drew JE; Marshall VF
    J Urol; 1968 Jun; 99(6):740-3. PubMed ID: 4968248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.